Estrella Immunopharma, Inc.
SEC Filing List
ESLA CIK: 0001844417
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| DEF 14A | Definitive proxy statements | Estrella Immunopharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 05/27/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Estrella Immunopharma, Inc. | EdgarAgents LLC /fa | 05/18/2026 | |
| NT 10-Q | Notice under Rule 12b25 of inability to ... | Estrella Immunopharma, Inc. | EdgarAgents LLC /fa | 05/18/2026 | |
| SCHEDULE 13G | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 05/15/2026 | |||
| 10-K/A | Amendment to annual report pursuant to S... | Estrella Immunopharma, Inc. | EdgarAgents LLC /fa | 04/30/2026 | |
| 4 | Statement of changes in beneficial owner... | Xu Jiandong | EdgarAgents LLC /fa | 04/29/2026 | |
| 4 | Statement of changes in beneficial owner... | Xu Jiandong | EdgarAgents LLC /fa | 04/29/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Estrella Immunopharma, Inc. | EdgarAgents LLC /fa | 03/18/2026 | |
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | Estrella Immunopharma, Inc. | EdgarAgents LLC /fa | 02/13/2026 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 01/23/2026 | ||
| No record found. | |||||
| Load More | |||||
